Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
ATARA BIOTHERAPE RG (NQ: ATRA)
42.25 USD  -3.80 (-8.25%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,080,236
Open 46.05
Bid (Size) 42.25 (2500)
Ask (Size) 51.00 (100)
Prev. Close 46.05
Today's Range 41.15 - 46.15
52wk Range 12.65 - 54.45
Shares Outstanding 43,949,486
Dividend Yield N/A
Performance
YTD
+133.43%
+133.43%
1 Month
-14.99%
-14.99%
3 Month
+6.56%
+6.56%
6 Month
+170.83%
+170.83%
1 Year
+186.44%
+186.44%
Top News
More News
Atara Biotherapeutics’ Tab-cel™ Achieves Positive Long-Term Outcomes in Phase 2 Studies of Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today... Read More
from GlobeNewswire News Releases
Atara Biotherapeutics Announces Publication of New Research Linking Epstein-Barr Virus (EBV) Infection and Multiple Sclerosis (MS)
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today... Read More
from GlobeNewswire News Releases
More News
Read More
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
Atara Biotherapeutics Announces Appointment of Utpal Koppikar as Chief Financial Officer
from GlobeNewswire News Releases
Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences
from GlobeNewswire News Releases
New Research Coverage Highlights Seaboard, The Hanover Insurance Group, Atara Biotherapeutics, Plexus, NV5 Global, and Analogic — Consolidated Revenues, Company Growth, and Expectations for 2018
from GlobeNewswire News Releases
Biotech Market Value Set to Grow Due to Technological Advancements
from PR Newswire
Atara Biotherapeutics to Present Long-Term Tab-cel™ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Associat
from GlobeNewswire News Releases
First Week of August 17th Options Trading For Atara Biotherapeutics (ATRA)
category Stocks
from Market News Video
Small Caps And Blue Chips Lead; Stocks Attempt Breakouts
from Investor's Business Daily
2 High-Flying Biotech Stocks With Even More Room to Grow
category ATRA , VRTX , Market News , and 3 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.